Darifenacin
In the US, Darifenacin (darifenacin systemic) is a member of the drug class urinary antispasmodics and is used to treat Overactive Bladder and Urinary Incontinence.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
G04BD10
CAS registry number (Chemical Abstracts Service)
0133099-04-4
Chemical Formula
C28-H30-N2-O2
Molecular Weight
426
Therapeutic Categories
Antispasmodic agent
Muscarinic receptor antagonist (anticholinergic, parasympatholytic agent)
Urological
Chemical Names
(S)-1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide (WHO)
(S)-1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-Õ,α-diphenylpyrrolidin-3-acetamid (IUPAC)
(S)-2-{1-[2-(2,3-Dihydrobenzo[b]furan-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide (BAN)
Foreign Names
- Darifenacinum (Latin)
- Darifenacin (German)
- Darifénacine (French)
- Darifenacina (Spanish)
Generic Names
- Darifenacin (OS: BAN, USAN)
- Dasifenacin (IS)
- UK 88525 (IS: Pfizer)
- Darifenacin Hydrobromide (OS: BANM, USAN)
- UK 88525-04 (IS: Pfizer)
Brand Names
- Emselex
Novartis, Norway; Novartis, Portugal; Novartis Europharm, Poland - Enablex
Bayer Schering, South Africa - Xelena
Dr. Reddy's, India - Continex
Baliarda, Argentina - Darisec
Elea, Argentina - Emselex
Bayer Vital, Germany; Novartis, Belgium; Novartis, Switzerland; Novartis, Czech Republic; Novartis, Denmark; Novartis, Finland; Novartis, United Kingdom; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Lithuania; Novartis, Netherlands; Novartis, Serbia; Novartis, Sweden; Novartis, Slovenia; Novartis, Slovakia; Novartis, Turkey; Novartis Europharm Limited, Latvia - Enablex
Bago, Argentina; Novartis, Australia; Novartis, Canada; Novartis Healthcare, Philippines; Warner Chilcott, United States - Esmelex
Novartis, Greece
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
